These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Foscarnet-induced severe hypomagnesemia and other electrolyte disorders. Gearhart MO; Sorg TB Ann Pharmacother; 1993 Mar; 27(3):285-9. PubMed ID: 8384030 [TBL] [Abstract][Full Text] [Related]
3. A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. Jacobson MA; Causey D; Polsky B; Hardy D; Chown M; Davis R; O'Donnell JJ; Kuppermann BD; Heinemann MH; Holland GN J Infect Dis; 1993 Aug; 168(2):444-8. PubMed ID: 8393058 [TBL] [Abstract][Full Text] [Related]
4. Treatment of cytomegalovirus retinitis with ganciclovir and foscarnet. Coker RJ; Tomlinson D; Horner P; Migdal C; Harris JR Lancet; 1991 Aug; 338(8766):574-5. PubMed ID: 1678829 [No Abstract] [Full Text] [Related]
5. Foscarnet treatment in various cytomegalovirus infections. Brockmeyer NH; Hengge UR; Mertins L; Malessa R; Steinmetz R; Gooss M Int J Clin Pharmacol Ther Toxicol; 1993 Apr; 31(4):204-7. PubMed ID: 8388868 [TBL] [Abstract][Full Text] [Related]
6. A protocol for foscarnet administration. Smith DG; Handy CM J Intraven Nurs; 1992; 15(5):274-7. PubMed ID: 1336798 [TBL] [Abstract][Full Text] [Related]
7. Foscarnet in the treatment of cytomegalovirus esophagitis. Nelson MR; Hawkins DA; Gazzard BG Am J Med; 1993 Apr; 94(4):446-7. PubMed ID: 8386438 [No Abstract] [Full Text] [Related]
8. Intravitreal foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome. Pearson PA; Jaffe GJ; Ashton P Am J Ophthalmol; 1993 May; 115(5):686-8. PubMed ID: 8387726 [No Abstract] [Full Text] [Related]
9. Foscarnet and Ganciclovir in the treatment of CMV retinitis in AIDS patients: a randomised comparison. Moyle G; Harman C; Mitchell S; Mathalone B; Gazzard BG J Infect; 1992 Jul; 25(1):21-7. PubMed ID: 1326012 [TBL] [Abstract][Full Text] [Related]
10. 2.5 years survival with sequential ganciclovir/foscarnet treatment in a patient with acquired immune deficiency syndrome and cytomegalovirus retinitis. Geier SA; Klauss V; Matuschke A; Kronawitter U; Goebel FD Ger J Ophthalmol; 1992; 1(2):110-3. PubMed ID: 1335812 [TBL] [Abstract][Full Text] [Related]
14. Relationship between foscarnet exposure, baseline cytomegalovirus (CMV) blood culture and the time to progression of CMV retinitis in HIV-positive patients. Drusano GL; Aweeka F; Gambertoglio J; Jacobson M; Polis M; Lane HC; Eaton C; Martin-Munley S AIDS; 1996 Sep; 10(10):1113-9. PubMed ID: 8874628 [TBL] [Abstract][Full Text] [Related]
15. Increased survival of a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis who received sodium phosphonoformate (foscarnet). Polis MA; deSmet MD; Baird BF; Mellow S; Falloon J; Davey RT; Kovacs JA; Palestine AG; Nussenblatt RB; Masur H Am J Med; 1993 Feb; 94(2):175-80. PubMed ID: 8381583 [TBL] [Abstract][Full Text] [Related]
16. Penile erosions associated with foscarnet therapy in a child. Hick RW; Prose N Pediatr Dermatol; 2010; 27(3):302-3. PubMed ID: 20609154 [TBL] [Abstract][Full Text] [Related]